Startseite › Endometriumkarzinom › Massachusetts › Boston
Klinische Studien zu Endometriumkarzinom in Boston, MA
50 Studien zu Endometriumkarzinom suchen Teilnehmer an Standorten in und um Boston (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Teilnehmer gesuchtPhase 2
- Tufts Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
Teilnehmer gesucht
- Dana-Farber Cancer Institute, Boston
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Teilnehmer gesuchtPhase 3
- Dana-Farber Cancer Institute, Boston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Teilnehmer gesuchtPhase 2
- Dana-Farber Cancer Institute - Oncology Department, Boston
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Dana Farber Cancer Institute, Boston
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Research Site, Boston
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber / Harvard Cancer Center, Boston
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute Brookline Avenue, Boston
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Teilnehmer gesuchtPhase 2
- Massachusetts General Hospital Cancer Center, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Dana Farber Cancer Institute, Boston
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Teilnehmer gesuchtPhase 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Teilnehmer gesuchtPhase 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Teilnehmer gesuchtPhase 3
- Tufts Medical Center ( Site 6052), Boston
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
ALPINE: Maintenance Letrozole/Abemaciclib
Teilnehmer gesuchtPhase 2
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Teilnehmer gesuchtPhase 1/2
- Research Site, Boston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Teilnehmer gesuchtPhase 1
- Dana Farber Cancer Institute, Boston
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Teilnehmer gesuchtPhase 1
- Dana-Farber Cancer Institute, Boston
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Dana-Farber Cancer Institute, Boston
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Teilnehmer gesuchtPhase 3
- Research Site, Boston
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia
Teilnehmer gesucht
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Teilnehmer gesuchtPhase 1
- Mass General Cancer Center, Boston
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Dana-Farber Cancer Institute, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Teilnehmer gesuchtPhase 1/2
- Dana-Farber Cancer Institute, Boston
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Dana Farber Cancer Institute, Boston
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Research Site, Boston
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Teilnehmer gesuchtPhase 2
- Dana Farber Cancer Institute, Boston
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Teilnehmer gesuchtPhase 1
- Normunity Investigational Site, Boston
- Normunity Investigational Site, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of PHST001 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Dana Farber Cancer Institute, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital Cancer Center, Boston
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Teilnehmer gesuchtPhase 1
- Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
A Study of LY4175408 in Participants With Advanced Cancer
Teilnehmer gesuchtPhase 1
- Massachusetts General Hospital, Boston
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
Teilnehmer gesuchtPhase 2
- Massachusetts General Hospital Cancer Center, Boston
- Beth Israel Deaconess Medical Center (BIDMC), Boston
- Dana Farber Cancer Institute, Boston
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Dana-Farber Cancer Institute, Boston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Teilnehmer gesuchtPhase 1
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
Teilnehmer gesucht
- Dana Farber Cancer Institute, Boston
Avelumab and M1774 in ARID1A-mutated Endometrial Cancer
Teilnehmer gesuchtPhase 2
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Teilnehmer gesuchtPhase 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Dana Farber Cancer Institute, Boston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Teilnehmer gesuchtPhase 1/2
- Massachusetts General Hospital, Boston
Comprehensive Outcomes for After Cancer Health
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Dana Farber Cancer Institute, Boston
Endometriumkarzinom-Studien in anderen Städten
- Houston, TX68 Studien
- New York City, NY52 Studien
- Arlington, VA39 Studien
- Nashville, TN38 Studien
- Los Angeles, CA34 Studien
- St. Louis, MO29 Studien
- Philadelphia, PA28 Studien
- San Antonio, TX27 Studien
- Chicago, IL25 Studien
- Columbus, OH25 Studien
- Queens, NY25 Studien
- Oklahoma City, OK25 Studien
Weitere Studien in Boston
- Brustkrebs111 Studien
- Nichtkleinzelliges Lungenkarzinom90 Studien
- Krebs (alle Arten)86 Studien
- Kolorektales Karzinom63 Studien
- Metastasierender Krebs63 Studien
- Lungenkrebs62 Studien
- Eierstockkrebs61 Studien
- Prostatakrebs59 Studien
- Depression52 Studien
- Herzinsuffizienz44 Studien
- Akute myeloische Leukämie44 Studien
- Bauchspeicheldrüsenkrebs43 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.